PB Handbook for Psychiatric Trainees
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2001) 25: 465-466. doi: 10.1192/pb.25.12.465
© 2001 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, J.
Right arrow Articles by Clark, A. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Johnson, J.
Right arrow Articles by Clark, A. F.
Psychiatric Bulletin (2001) 25: 465-466
© 2001 The Royal College of Psychiatrists

Prescribing of unlicensed medicines or licensed medicines for unlicensed applications in child and adolescent psychiatry

Joanne Johnson, Research Assistant and Andrew F. Clark, Senior Lecturer in Adolescent Psychiatry

University of Manchester, Mental Health Services of Salford NHS Trust, Bury New Road, Manchester M25 3BL

Correspondence: (tel: 0161772 3648; fax 0161772 3593; e-mail: andrew.clark{at}man.ac.uk )

AIMS AND METHOD

Child and adolescent mental health services in north-west England (n=21) participated in a prospective collection of information regarding all instances of new prescribing of medication over the 6-month period September 1999 to February 2000.

RESULTS

A total of 478 new prescriptions were issued to 411 individuals. Eight prescriptions (2%) were for an unlicensed drug and a further 188 (39%) were of licensed drugs but used in a manner outside of their product licence.

CLINICAL IMPLICATIONS

This level of unlicensed and outside-licence prescribing is similar to levels previously found in studies both within paediatric practice and in adult mental health practice. Anxiety about excessive beyond-licence prescribing by child mental health services is unlikely to be justified.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
A. F. Clark
Incidences of New Prescribing by British Child and Adolescent Psychiatrists: a Prospective Study Over 12 Months
J Psychopharmacol, March 1, 2004; 18(1): 115 - 120.
[Abstract] [PDF]


Home page
Psychiatr. Bull.Home page
U. A Doerry and L. Kent
Prescribing practices of community child and adolescent psychiatrists
Psychiatr. Bull., November 1, 2003; 27(11): 407 - 410.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2001 The Royal College of Psychiatrists.